Testosterone Implants and the Incidence of Breast Cancer
NCT03768258 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1268
Last updated 2021-09-05
Summary
This current chart review study was designed to investigate the incidence of breast cancer in women treated with subcutaneous testosterone therapy for symptoms of hormone deficiency.
Conditions
Interventions
- DRUG
-
Testosterone Implant
Testosterone implants or combination testosterone + anstrozole implants used to treat symptoms of hormone/androgen deficiency
Sponsors & Collaborators
-
Millennium Wellness LLC
lead OTHER
Eligibility
- Min Age
- 24 Years
- Max Age
- 92 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-03-31
- Primary Completion
- 2018-03-31
- Completion
- 2018-12-31
More Related Trials
-
Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer
NCT00290758 ·Status: COMPLETED ·Phase: PHASE2
-
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
NCT00016432 ·Status: COMPLETED ·Phase: PHASE3
-
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer
NCT00032136 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in Children
NCT00458588 ·Status: COMPLETED
-
Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer
NCT00066586 ·Status: COMPLETED ·Phase: NA
-
Individuals on Hormone Therapy Breast Cancer Screening Pilot
NCT06383026 ·Status: RECRUITING
-
Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer
NCT02161315 ·Status: UNKNOWN
-
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment
NCT05928325 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Compliance to a Hormone Therapy Regimen in Breast Cancer
NCT00666822 ·Status: COMPLETED
-
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
NCT00003771 ·Status: COMPLETED ·Phase: PHASE3
-
Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer
NCT01654367 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer
NCT00569543 ·Status: COMPLETED
-
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
NCT00083174 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
NCT01385280 ·Status: COMPLETED ·Phase: NA
-
Diindolylmethane in Treating Patients With Breast Cancer
NCT01391689 ·Status: COMPLETED ·Phase: NA
-
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy
NCT01697345 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations
NCT06926530 ·Status: NOT_YET_RECRUITING
-
Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen
NCT00764322 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of DIM Supplements to Increase 2-OHE1/16 Ratio
NCT02525159 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
NCT00238316 ·Status: COMPLETED ·Phase: PHASE2
-
Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer
NCT00562458 ·Status: COMPLETED
-
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
NCT01077453 ·Status: COMPLETED ·Phase: PHASE1
-
Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer
NCT04693338 ·Status: COMPLETED ·Phase: PHASE1
-
Chronic Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer
NCT06776458 ·Status: RECRUITING
-
Melatonin Versus Placebo in Breast Cancer
NCT01805089 ·Status: COMPLETED ·Phase: EARLY_PHASE1